Journal article
High‐dose cytosine arabinoside in the treatment of preleukemic disorders: A leukemia intergroup study
Abstract
Fifteen patients with myelodysplastic/myeloproliferative disorders were treated with high-dose cytosine arabinoside therapy. While severe toxicity was produced in every patient, only two of the 15 patients entered complete remission and two achieved partial remission status. The therapeutic responses were confined to patients who had severe myelofibrosis of apparently recent onset.
Authors
Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Browman G; Walker I; Grunwald H; D'Arrigo P; Stein A
Journal
American Journal of Hematology, Vol. 23, No. 2, pp. 131–134
Publisher
Wiley
Publication Date
October 1986
DOI
10.1002/ajh.2830230207
ISSN
0361-8609